RNA测序揭示胃旁路术后肠道L细胞新组分及GLP-1分泌机制
本研究对13例Roux-en-Y胃旁路术(RYGB)患者术前及术后1年空肠样本行RNA-seq,发现胆固醇生物合成通路受影响最显著;体外沉默或抑制硬脂酰辅酶A去饱和酶1(SCD1)可降低GLUTag与STC-1细胞的Gcg表达及GLP-1分泌,小鼠实验提示SCD1参与调控L细胞密度与Gcg mRNA表达。
要点
- RYGB术后1年空肠转录组改变显著,胆固醇生物合成通路受影响最大。
- 抑制SCD1降低GLUTag与STC-1细胞的Gcg表达和GLP-1分泌。
- 肠道特异性Scd1敲除小鼠空肠L细胞密度与Gcg mRNA表达均升高两倍。
核心结论
- RYGB引起空肠转录组显著改变,其中胆固醇生物合成相关基因受影响最大。
- SCD是RYGB调控的L细胞组分,参与调控GLP-1的产生与分泌。
研究设计与样本
- 人空肠样本取自围手术期及RYGB术后1年(n=13),行RNA-seq分析。
- 体外使用GLUTag与STC-1细胞,以siRNA靶向四个胆固醇生物合成相关基因。
- 体内行C57BL/6j与iScd1-/-小鼠OGTT,并行离体免疫组化与基因表达分析。
主要发现
- 基因本体(GO)分析显示胆固醇生物合成受RYGB影响最大。
- 沉默或化学抑制SCD1可降低GLUTag与STC-1细胞的Gcg表达及GLP-1分泌。
- Scd1敲低降低细胞内Ca2+信号与膜去极化。
- Scd1 mRNA表达受非酯化脂肪酸(NEFA)调控而不受葡萄糖调控。
- SCD1抑制剂处理的GLUTag细胞RNA-seq显示ATP生成与糖酵解相关基因表达改变。
关键数值与推荐
- 人空肠样本n=13,取自围手术期及RYGB术后1年。
- iScd1-/-小鼠空肠L细胞密度为两倍升高,Gcg mRNA表达为两倍增加。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Roux-en-Y gastric bypass surgery (RYGB) frequently results in remission of type 2 diabetes as well as exaggerated secretion of glucagon-like peptide-1 (GLP-1). Here, we assessed RYGB-induced transcriptomic alterations in the small intestine and investigated how they were related to the regulation of GLP-1 production and secretion in vitro and in vivo. METHODS: Human jejunal samples taken perisurgically and 1 year post RYGB (n=13) were analysed by RNA-seq. Guided by bioinformatics analysis we targeted four genes involved in cholesterol biosynthesis, which we confirmed to be expressed in human L cells, for potential involvement in GLP-1 regulation using siRNAs in GLUTag and STC-1 cells. Gene expression analyses, GLP-1 secretion measurements, intracellular calcium imaging and RNA-seq were performed in vitro. OGTTs were performed in C57BL/6j and iScd1-/- mice and immunohistochemistry and gene expression analyses were performed ex vivo. RESULTS: Gene Ontology (GO) analysis identified cholesterol biosynthesis as being most affected by RYGB. Silencing or chemical inhibition of stearoyl-CoA desaturase 1 (SCD1), a key enzyme in the synthesis of monounsaturated fatty acids, was found to reduce Gcg expression and secretion of GLP-1 by GLUTag and STC-1 cells. Scd1 knockdown also reduced intracellular Ca2+ signalling and membrane depolarisation. Furthermore, Scd1 mRNA expression was found to be regulated by NEFAs but not glucose. RNA-seq of SCD1 inhibitor-treated GLUTag cells identified altered expression of genes implicated in ATP generation and glycolysis. Finally, gene expression and immunohistochemical analysis of the jejunum of the intestine-specific Scd1 knockout mouse model, iScd1-/-, revealed a twofold higher L cell density and a twofold increase in Gcg mRNA expression. CONCLUSIONS/INTERPRETATION: RYGB caused robust alterations in the jejunal transcriptome, with genes involved in cholesterol biosynthesis being most affected. Our data highlight SCD as an RYGB-regulated L cell constituent that regulates the production and secretion of GLP-1.
引用
- Miskelly MG, Lindqvist A, Piccinin E, et al. RNA sequencing unravels novel L cell constituents and mechanisms of GLP-1 secretion in human gastric bypass-operated intestine. Diabetologia. 2023. PMID: 38032369. doi:10.1007/s00125-023-06046-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。